Evaxion to present CMV vaccine data at Montreal conference

July 1, 2026 8:00 AM

Evaxion A/S (NASDAQ: EVAX) will present new preclinical data for its cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found